Regulating the Absurd: ‘Killer Robots’ and the Morality Behind Arms Regulations
Global Geopolitics · 2026
DOI: 10.64901/29778271.2026.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Geopolitics, 2026. Verfasst von Jan Falgueras-Riu. Die Arbeit nennt 81 Literaturangaben.
Abstract (Originalsprache)
The rapid development of Lethal Autonomous Weapons Systems (LAWS) has intensified debates over the adequacy of existing legal and ethical frameworks governing armed conflict. This article examines how the ethical concerns associated with autonomous weapons can be adequately addressed through existing legal obligations or whether they introduce novel moral challenges demanding new regulatory standards. Methodologically, the study employs qualitative content analysis of academic, legal, and policy debates concerning the regulation of LAWS, identifying and categorizing the principal moral arguments advanced in contemporary discussions. The findings reveal three broad categories of concerns: challenges related to compliance with existing IHL principles, unprecedented ethical issues arising from the autonomous exercise of lethal force, and intensified moral risks shared with other unmanned weapon systems. The article argues that, regardless of their potential legal compliance, LAWS fundamentally transform the relationship between human agency and lethal force, thereby necessitating additional normative standards centered on meaningful human control.
Zitieren
APA
Falgueras-Riu, J. (2026). Regulating the Absurd: ‘Killer Robots’ and the Morality Behind Arms Regulations. Global Geopolitics. https://doi.org/10.64901/29778271.2026.018
Vancouver
Falgueras-Riu J. Regulating the Absurd: ‘Killer Robots’ and the Morality Behind Arms Regulations. Global Geopolitics. 2026. doi:10.64901/29778271.2026.018
BibTeX
@article{FalguerasRiu2026,
author = {Falgueras-Riu, Jan},
title = {Regulating the Absurd: ‘Killer Robots’ and the Morality Behind Arms Regulations},
journal = {Global Geopolitics},
year = {2026},
doi = {10.64901/29778271.2026.018}
}
EUVIMED